Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combined formula for treating inflammatory bowel disease

A technology of inflammatory bowel disease and formulation, applied in the direction of drug combination, pharmaceutical formulation, allergic diseases, etc., can solve the problems of unsatisfactory effect and large side effects, and achieve the effects of prolonging human life, good therapeutic effect, and enhancing blood supply

Inactive Publication Date: 2016-04-06
何松庆
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] 1. 0.5 grams of ganoderma lucidum, 0.6 grams of salvia miltiorrhiza, 0.5 grams of threonine, 50 mg of vitamin C, 4 mg of vitamin E, 0.1 mg of vitamin A, and 0.6 mg of β-carotene are made into chewing agents, 2 to 4 times a day.

[0028] 2. 0.25 grams of Ganoderma lucidum, 0.3 grams of Salvia miltiorrhiza, 0.25 grams of threonine, 25 mg of vitamin C, 2 mg of vitamin E, 0.05 mg of vitamin A, and 0.3 mg of β-carotene are made into chewing agents, 2 to 4 times a day.

[0029] 3. 0.5 grams of Ganoderma lucidum, 0.6 grams of Salvia miltiorrhiza, 0.5 grams of threonine, 50 mg of vitamin C, 4 mg of vitamin E, 0.1 mg of vitamin A, and 0.6 mg of β-carotene are made into medicines, 2 to 4 times a day.

[0030] 4. Ganoderma lucidum 0.25g, Salvia miltiorrhiza 0.3g, threonine 0.25g, vitamin C 25mg, vitamin E 2mg, vitamin A 0.05mg, β-carotene 0.3mg made into a medicine, 2 to 4 times a day.

[0031] 5. 5 grams of ganoderma lucidum, 6 grams of salvia miltiorrhiza, 0.5 grams of threonine...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a combined formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula consists of lucid ganoderma, radix salviae miltiorrhizae, threonine, vitamin C, vitamin E, vitamin A and beta-carotene. The lucid ganoderma and the radix salviae miltiorrhizae have functions of enhancing blood supply and oxygen supply of a human body; the threonine is a constituent part of mucoprotein; and the vitamin C, the vitamin E, the vitamin A and the beta-carotene have functions of depressing the activity of oxygen radical, eliminating the oxygen radical and protecting body cells. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of the mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.

Description

technical field [0001] The invention relates to a combination formula of Chinese medicinal materials, amino acids and vitamins for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P29/00A61P1/00A61P1/12A61P11/06A61P11/14A61P11/02A61P37/08A61K31/198A61K31/375A61K31/355A61K31/07A61K31/015
CPCA61K9/0053A61K9/0056A61K31/015A61K31/07A61K31/198A61K31/355A61K31/375A61K36/074A61K36/537A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com